CLEXBIO
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.
CLEXBIO
Industry:
Health Care
Founded:
2020-01-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.clexbio.com
Total Employee:
1+
Status:
Active
Total Funding:
2.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Amazon Google Apps For Business Cloudflare JS CDN JS AJAX Libraries API
Similar Organizations
Braive
Braive develops and delivers online-based Cognitive Behavioural Therapy (CBT) treatment programs for healthcare, businesses and individuals.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Habitual
Digital therapeutics & nutritional treatment for type 2 diabetes reversal.
Hoth Intelligence
Seeing is everything. We use augmented reality to make healthcare better.
Push Doctor
Push Doctor is creating the future of healthcare.
Current Employees Featured
Manuel Schweikle CSO & Co-Founder @ ClexBio
CSO & Co-Founder
2020-04-01
Armend G. Håti CEO & Co-Founder @ ClexBio
CEO & Co-Founder
2020-01-01
Founder
Official Site Inspections
http://www.clexbio.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "ClexBio"
ClexBio | Next-Generation Tissue Therapeutics
ClexBio is a pre-clinical tissue therapeutics company with a next-generation technology platform enabling scalable, high-throughput generation of lab-grown tissuesSee details»
ClexBio - Crunchbase Company Profile & Funding
ClexBio is a pre-clinical stage regenerative medicine company that has developed a ground-breaking proprietary technology platform for scalable, high-throughput tissue generation.See details»
ClexBio | Lab Manager
Jul 9, 2021 ClexBio is a Norway-based biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with the …See details»
About Us | Next-Generation Tissue Therapeutics - ClexBio
ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough proprietary technology platform for scalable, high-throughput tissue generation.See details»
ClexBio - LinkedIn
ClexBio is a preclinical-stage regenerative medicine company with a breakthrough platform for scalable, high-throughput generation of therapeutic tissues. We represent the next generation of cell ...See details»
ClexBio – NOME
ClexBio’s co-founders Armend G. Håti and Manuel Schweikle have academic and industrial expertise from leading universities and biotechs globally. ClexBio is located in Oslo, Norway, …See details»
ClexBio Company Profile - Office Locations, Competitors ... - Craft
ClexBio has 5 employees across 2 locations and $2.2 m in total funding,. See insights on ClexBio including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
ClexBio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for ClexBio. Use the PitchBook Platform to explore the full profile.See details»
☑️Nordovo Biosciences AS (ClexBio) — Consulting Organization …
Dec 6, 2024 ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough proprietary technology platform for scalable, high-throughput tissue generation. Our team …See details»
ClexBio Secures Strategic Investments from GG 1978 and EQT …
Nov 22, 2024 ClexBio is pleased to announce new investments by GG 1978 and EQT Foundation. These investments represent a significant endorsement of ClexBio's mission to …See details»
ClexBio - Funding, Financials, Valuation & Investors - Crunchbase
ClexBio, we envision a world where no patient needs to die while waiting for an organ transplant.See details»
ClexBio | Lab Manager
ClexBio ClexBio is a Norway-based biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with the …See details»
ClexBio - Products, Competitors, Financials, Employees, …
ClexBio is a preclinical-stage regenerative medicine company that develops bioengineered tissues within the tissue therapeutics sector. The company's offerings include the creation of …See details»
ClexBio - eqtfoundation.com
Nov 22, 2024 About the solution Founded by Armend Håti, ClexBio is a biotechnology company developing the next generation of tissue therapies to address chronic diseases, starting with …See details»
ClexBio - Updates, News, Events, Signals & Triggers - Crunchbase
ClexBio may be growing as it has been reported to collaborate with CSEM to create a bioreactor for tissue-engineered cardiovascular implants, indicating an expansion in its research and …See details»
EQT Foundation backs ClexBio, transforming the future of tissue ...
Nov 22, 2024 EQT Foundation joins a funding round for ClexBio to accelerate the development of bioengineered tissues ClexBio’s proprietary platform offers a new approach to creating …See details»
ClexBio – Funding, Valuation, Investors, News - Parsers VC
Essential stats, news, real-time insights on ClexBio. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
Young entrepreneurs expand to engineer tissue for organ …
The startup ClexBio in Oslo is a result of entrepreneurial love at first sight. The long-term goal of the founders is to engineer human tissue such as blood vessels for clinical transplantation. …See details»
Technology - clexbio.com
Our VivoSet™ tissue engineering technology provides ideal conditions for co-culture of human cells to create anatomical features found in the body, such as microvasculature and …See details»
ClexBio AG – Swiss Biotech
The Future Rewritten: Unlocking Genome Editing. By fusing directed evolution, high-throughput characterization, and AI, Nerai creates novel CRISPR editors, more precise and more …See details»